Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for a “unified approach” to strengthen Europe’s pharmaceutical framework an | Facing drug pricing pressure from the U.S., Belgium, the Netherlands, Luxembourg, Austria and Ireland stressed the need for "collaborative efforts across the Union" in a June 10 statement.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in…

In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and…

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the…

There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…

With questions already swirling about the actual affordability impact of t | With questions already swirling about the actual…

As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…